GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (ISX:KLBF) » Definitions » 1-Year ROIIC %

PT Kalbe Farma Tbk (ISX:KLBF) 1-Year ROIIC % : -158.29% (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is PT Kalbe Farma Tbk 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. PT Kalbe Farma Tbk's 1-Year ROIIC % for the quarter that ended in Mar. 2024 was -158.29%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for PT Kalbe Farma Tbk's 1-Year ROIIC % or its related term are showing as below:

ISX:KLBF's 1-Year ROIIC % is ranked worse than
88.34% of 935 companies
in the Drug Manufacturers industry
Industry Median: 1.7 vs ISX:KLBF: -158.29

PT Kalbe Farma Tbk 1-Year ROIIC % Historical Data

The historical data trend for PT Kalbe Farma Tbk's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk 1-Year ROIIC % Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.02 -108.54 23.52 3.95 -46.68

PT Kalbe Farma Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 -1.43 -16.13 -46.68 -158.29

Competitive Comparison of PT Kalbe Farma Tbk's 1-Year ROIIC %

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's 1-Year ROIIC % falls into.



PT Kalbe Farma Tbk 1-Year ROIIC % Calculation

PT Kalbe Farma Tbk's 1-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 2872203.3574 (Mar. 2024) - 3320463.0635 (Mar. 2023) )/( 21470945.156 (Mar. 2024) - 21187752.015 (Mar. 2023) )
=-448259.7061/283193.141
=-158.29%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


PT Kalbe Farma Tbk  (ISX:KLBF) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


PT Kalbe Farma Tbk 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk (ISX:KLBF) Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (ISX:KLBF) Headlines

No Headlines